Overall Learning Objectives
At the end of this meeting, participants will be able to:
- Integrate emerging advances in the diagnosis, prevention, and management of cardiac arrhythmias including artificial intelligence, novel device technologies, and advances in ventricular tachycardia and atrial fibrillation management into evidence-informed clinical decision-making. (Medical Expert, Collaborator, Scholar, Leader)
- Apply current Canadian and international guideline recommendations and consensus statements related to cardiac implantable electronic devices, conduction system pacing, and arrhythmia management to optimize patient care across diverse clinical settings. (Medical Expert, Collaborator, Scholar, Leader)
- Recognize sex- and gender-specific considerations in arrhythmia diagnosis, risk assessment, and treatment and incorporate these factors into individualized patient management strategies. (Medical Expert, Collaborator, Scholar, Leader)
- Critically evaluate emerging electrophysiology research, technologies, and clinical trial data and identify opportunities to translate new evidence into practice to improve patient outcomes. (Medical Expert, Collaborator, Scholar, Leader)
- Collaborate with multidisciplinary teams and international experts to exchange knowledge, foster professional networks, and advance best practices in cardiac electrophysiology and heart rhythm care. (Medical Expert, Collaborator, Scholar, Leader)
Session Specific Learning Objectives
Friday September 11, 2026
SESSION 1: FELLOWS & ALLIED HEALTH PROFESSIONAL PROGRAM
Following this session, participants will be able to:
- Develop an approach to supraventricular tachycardia, ventricular tachycardia and atrial fibrillation. (Medical Expert, Collaborator, Scholar)
- Participate in Fellows case presentations sessions addressing basic and advanced concepts in the field of cardiac arrhythmias. (Medical Expert, Collaborator, Scholar)
Saturday September 12, 2026
SESSION 1: WHAT’S NEW IN 2026?
Following this session, participants will be able to:
- Describe newer pacing and defibrillation modalities and their potential clinical applications. (Medical Expert, Collaborator, Scholar, Leader)
- Identify new markers for ICD patients’ detection post MI with LV dysfunction. (Medical Expert, Collaborator, Scholar, Leader)
- Describe emerging therapies for the invasive management of ventricular tachycardia. (Medical Expert, Collaborator, Scholar, Leader)
- Examine applications of artificial intelligence in arrhythmia diagnosis, risk stratification, and management. (Medical Expert, Collaborator, Scholar, Leader)
SESSION 2: SEX DIFFERENCES IN ARRHYTHMIA (Joint HRS/CHRS)
Following this session, participants will be able to:
- Compare sex-specific patterns in the incidence, presentation, and risk factors of ventricular arrhythmia and atrial fibrillation. (Medical Expert, Collaborator, Scholar, Leader)
- Identify evidence describing sex-specific atrial fibrillation outcomes. (Medical Expert, Collaborator, Scholar, Leader)
- Differentiate sex-specific features across selected channelopathies. (Medical Expert, Collaborator, Scholar, Leader)
- Assess the potential impact of gender-affirming therapies on channelopathy presentation and management. (Medical Expert, Collaborator, Scholar, Leader)
ORAL ABSTRACT PRESENTATIONS
Following this session, participants will be able to:
- Critically analyze emerging evidence in the Canadian electrophysiology field. (Medical Expert, Scholar)
- Translate new research findings into clinical practice by integrating advances in technology, imaging, and patient-specific interventions to improve outcomes in cardiac rhythm disorders. (Medical Expert, Scholar, Leader)
SESSION 3: DEVICES (Joint EHRA/CHRS)
Following this session, participants will be able to:
- Evaluate current indications for CSP, and how they are positioned with respect to standard and biventricular pacing. (Medical Expert, Collaborator, Scholar, Leader)
- Identify conduction disorders following TAVR and outline evidence-informed management strategies. (Medical Expert, Collaborator, Scholar, Leader)
- Compare Canadian and EHRA guideline recommendations for device management. (Medical Expert, Collaborator, Scholar, Leader)
SESSION 5: ATRIAL FIBRILLATION (Joint Session AP-HRS/CHRS)
Following this session, participants will be able to:
- Differentiate rhythm-control and rate-control strategies for atrial fibrillation management. (Medical Expert, Collaborator, Scholar, Leader)
- Assess management of anticoagulation post ablation considering recent RCT results. (Medical Expert, Collaborator, Scholar, Leader)
- Interpret data on left atrial appendage closure and select appropriate patient criteria for LAAC. (Medical Expert, Collaborator, Scholar, Leader)
- Outline key operational and technical considerations for building a fluoroless electrophysiology lab. (Medical Expert, Collaborator, Scholar, Leader)